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ORIGINAL ARTICLE INFECTIOUS DISEASESPreterm infant gut colonization in the neonatal ICU and complete
restoration 2 years laterL. Moles1,2, M. Gómez1, E. Jiménez1,3, L. Fernández1,3, G. Bustos4,5, F. Chaves6,7, R. Cantón2,7,8, J. M. Rodríguez1,3 and
R. del Campo2,7,8
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Sanitarias (IRYCIS), 3) ProbiSearch, S.L., Tres Cantos, 4) Servicio de Neonatología Hospital Universitario 12 de Octubre, 5) Red de Salud Materno-Infantil y del
Desarrollo (SAMID), Instituto Carlos III, 6) Servicio de Microbiología, Hospital Universitario 12 de Octubre, 7) Servicio de Microbiología, Hospital Universitario
Ramón y Cajal and 8) Spanish Network for Research in Infectious Diseases (REIPI), Instituto de Salud Carlos III, Madrid, SpainAbstractPreterm infants in a neonatal intensive care unit (NICU) are exposed to multidrug-resistant bacteria previously adapted to the hospital
environment. The aim of the present study was to characterize the bacterial antibiotic-resistant high-risk lineages colonizing preterm
infants during their NICU stay and their persistence in faeces after 2 years. A total of 26 preterm neonates were recruited between
October 2009 and June 2010 and provided 144 faecal samples. Milk samples (86 mother’s milk, 35 human donor milk and 15 formula
milk) were collected at the same time as faecal samples. An additional faecal sample was recovered in 16 infants at the age of 2 years.
Samples were plated onto different selective media, and one colony per morphology was selected. Isolates were identiﬁed by 16S rDNA
nucleotide sequence and MALDI-TOF. Antibiotic susceptibility (agar dilution), genetic diversity (RAPD, PFGE and MLST) and virulence
factors (only in enterococcal and staphylococcal isolates) were determined by PCR. A high proportion of antibiotic-resistant high-risk
clones was detected in both faecal and milk samples during the NICU admittance. Almost all infants were colonized by Enterococcus
faecalis ST64 and Enterococcus faecium ST18 clones, while a wider genetic diversity was observed for the Gram-negative isolates.
Multidrug-resistant high-risk clones were not recovered from the faecal samples of the 2-year-olds. In conclusion, the gut of preterm
infants admitted to the NICU might be initially colonized by antibiotic-resistant and virulent high-risk lineages, which are later replaced by
antibiotic-susceptible community ones.
Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All
rights reserved.
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health, and its alterations have been implicated in severalMicrobiol Infect 2015; 21: 936.e1–936.e10
nical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infect
p://dx.doi.org/10.1016/j.cmi.2015.06.003systemic diseases, particularly in the early stages of life [1].
After birth, an adequate gut microbiota establishment is
essential for both the innate immune system maturation and the
creation of a barrier protection from bacterial pathogens [2,3].
Moreover, these ﬁrst bacterial cells colonizing our gut mucosa
might persist in symbiosis with our enterocytes throughout our
complete life.
Bacterial gut colonization starts during the intrauterine stage,
greatly increasing during delivery and the ﬁrst days of life [4–6].
This process can be adversely affected by numerous factors,
including antibiotic treatment, caesarean delivery, earlyious Diseases. Published by Elsevier Ltd. All rights reserved
TABLE 1. Demographic data and clinical characteristics of 26
preterm infants
Characteristic Value
Gestational age (weeks), mean (range) 28 (26.6–28.7)
Sex, M/F 13/13
Birth weight (g), mean (range) 1167 (987.3–1347.3)
z score, mean (range) −0.23 (−0.50 to 0.04)
Vaginal/caesarean section 12/14
Sepsis 7
Prophylactic antibiotic therapy at birth
No 1
Yes 25
<3 days 12
>3 days 13
Days with parenteral nutrition (n = 22), median (IQR) 10 (3–12)
Days with enteral feeding tube (n = 26) 59 (46–72)
Days with mechanical ventilation (n = 16), median (IQR) 14 (0–10)
Days with CPAP (n = 21), median (IQR) 18.5 (1.5–39)
Days with oxygen therapy (n = 20), median (IQR) 33.5 (1.5–39)
Days in NICU (n = 26), median (IQR) 52 (18–81)
Days at hospital (n = 26), median (IQR) 69 (41–92)
CPAP, continuous positive airway pressure; IQR, interquartile range; NICU,
neonatal intensive care unit.
CMI Moles et al. Preterm infant gut colonization 936.e2separation from the mother, formula feeding, invasive medical
treatments and long stays in neonatal intensive care units
(NICUs) [7,8]. Some of these factors are usually associated with
premature infants, who in addition have a delayed or aberrant
gut microbiota characterized by poor global bacterial diversity
and a low and rather ﬂuctuating Biﬁdobacterium population
[9–11].
During their usually long NICU stays, preterm infants are
exposed to multidrug-resistant bacteria previously adapted to
the hospital environment that have been recognized as high-risk
clones. Most of these high-risk clones belong to the ESKAPE
group (Enterococcus faecium, Staphylococcus aureus, Klebsiella
pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa
and Enterobacter species) [12,13]. Furthermore, these preterm
infants are usually treated with antibiotics which also select the
multidrug-resistant bacteria that might colonize their guts.
In the last few years, the implementations of metagenomic
tools based on 16S rDNAmassive sequence have providedmuch
information about the complexity of the gut microbiota
ecosystem [14], including the identiﬁcation of uncultured mi-
croorganisms. However, classical and extended techniques based
on classical microbiologic cultures such as culturomics also
provide a comprehensive approach for the human gutmicrobiota
study and allow us to further characterize bacterial isolates [15].
Although previous studies have assessed the gut colonization
of preterm infants, little is known about its evolution after
hospital discharge and in their ﬁrst years of life, particularly at
around 2 years of life, when a mature microbiota has been
already established. The aim of the present study was to
characterize the bacterial lineages colonizing premature infants
during their NICU admittance and their persistence after 2
years, which is the age when the child’s gut starts to contain an
adultlike microbiota [16,17].MethodsSubjects and sampling
Twenty-six preterm infants (32 weeks’ gestation and/or
weighing 1500 g) born between October 2009 and June 2010
in the 12 de Octubre University Hospital in Madrid were
included in the study. Preterm infants with malformations,
metabolic diseases or severe conditions were excluded. Rele-
vant demographic and clinical data are summarized in Table 1.
The local ethic committee approved the study (reference 09/
157), and parents signed informed consent. After the routine
NICU feeding protocols, all infants were preferably fed with
their own mother’s milk, and when this was not possible with
pasteurized human milk from the milk bank unit. When the
weight of the infants was 1500 g and their own mother’s milkClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infwas unavailable, they received adapted preterm formula. The
fortiﬁer FM 85 (Nestlé, Vevey, Switzerland) was used from
approximately the fourth week of life with an initial dose of 1 g
per 50 mL of milk, which was increased to 1 g per 20 mL.
Globally, the feeding patterns of the recruited infants were very
heterogeneous, a fact that prevented the formation of well-
deﬁned feeding groups.
The ﬁrst spontaneously evacuated meconium after delivery
and faecal samples were collected weekly during the ﬁrst month
of life, then every 15 days until discharged from the NICU.
Samples were collected and immediately stored at −80°C.
Once the infants were 2 years old, an additional faecal sample
was also collected, although we only were able to contact 16
out of the 26 families.
Mother’s milk was extracted using electric pumps and stored
either refrigerated for amaximumof 24 hours or frozen for up to
6months. Donormilk, pasteurized at 62.5°C after collection, has
a shelf life of 3 months. All milks were incubated for 10 to 15
minutes at 37°C to 40°C and were administered to the infant
through an orogastric or nasogastric feeding tube using a syringe
(manual feeding) or a pump (automatic feeding). Milk samples
were always collected after feeding from either the syringe or the
extension set connected with the orogastric or nasogastric
feeding tube at the same sampling times as the faecal ones.
Bacterial strains causing a bacteraemia were recovered from
the blood samples after their identiﬁcation was performed at
the Department of Microbiology at the 12 de Octubre Uni-
versity Hospital.
Culture analysis of the samples
Suitable dilutions of milk and faecal samples obtained during the
NICU stay were spread onto de Man Rogosa Sharpe mediumectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 936.e1–936.e10
936.e3 Clinical Microbiology and Infection, Volume 21 Number 10, October 2015 CMI(Oxoid, Basingstoke, UK) supplemented or not with L-cysteine
(0.5 g/L) (Sigma-Aldrich, St. Louis, MO, USA) for lactic acid
bacteria isolation; MacConkey agar (bioMérieux, Marcy l’Etoile,
France) for Enterobacteriaceae; Baird Parker agar (BioMérieux)
for staphylococci, brain–heart infusion broth (Oxoid), Wilkins-
Chalgren agar (Oxoid) and ﬁnally in Columbia nalidixic acid
(BioMérieux) as general agar media plates for isolation of bac-
terial organisms.
Persistence of selected antibiotic resistant strains acquired in
the NICU stay was evaluated in faecal samples of the 2-year-old
infants, on the one hand with selective agar media supple-
mented or not with antibiotics such as mannitol salt agar for
staphylococci (Difco Laboratories, Detroit, MI, USA) and M-
Enterococcus agar (Difco) alone and supplemented with 16 μg/
mL of ampicillin or 16 μg/mL of erythromycin, and on the other
hand with MacConkey plates supplemented with 4 μg/mL of
ciproﬂoxacin, or 2 μg/mL of imipenem or 1 μg/mL of
cefotaxime.
Plates were aerobically incubated at 37°C for up to 48 hours,
with the exception of the Wilkins-Chalgren and de Man Rogosa
Sharpe–cysteine plates, which were anaerobically incubated
(85% nitrogen, 10% hydrogen and 5% carbon dioxide) in an
anaerobic workstation (Mini-MACS Don Whitley Scientiﬁc
Limited, Shipley, UK) at 37°C for 48 hours. Bacterial counts
were recorded as colony-forming units (CFU) per gram of
meconium or faeces or as CFU per milliliter of milk, then
transformed to log10 values.
Bacterial identiﬁcation and genotyping
After the initial samples processing, ~4000 colonies were
selected including at least one colony per morphology, medium
and sample. Isolates were subcultured in brain–heart infusion
and de Man Rogosa Sharpe media. In order to avoid repeated
isolates, those with the same morphology from the same me-
dium and sample were submitted to randomly ampliﬁed poly-
morphic DNA PCR (RAPD-PCR) using the primer OPL5 (50-
ACGCAGGCAC-30) [18]. Finally, at least one representative
isolate from each sample, medium and infant was further
selected. Bacterial identiﬁcation was performed by matrix-
assisted laser desorption/ionization time-of-ﬂight mass spec-
trometry (MALDI-TOF) (Bruker Daltonics, Bremen, Germany)
combined with 16S rDNA PCR ampliﬁcation and further
nucleotide sequencing. Staphylococcal species belonging to the
species S. aureus, Staphylococcus epidermidis or Staphylococcus
hominis were identiﬁed by a multiplex PCR method based on
the dnaJ genes [4].
Genetic diversity
The genetic diversity of all selected isolates was assessed by
pulsed-ﬁeld gel electrophoresis (PFGE) in a CHEF DR IIClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectapparatus (Bio-Rad, Birmingham, UK). To separate SmaI-
digested fragments of enterococci and staphylococci, different
protocols were applied (2 to 28 seconds for 24 hours; and 5
to 15 seconds for 10 hours and then 15 to 60 seconds for 13
hours, respectively). The chromosomal DNA of
K. pneumoniae isolates was digested with XbaI enzyme, and
the electrophoresis conditions were 1 to 40 seconds for 20
hours. Dendrogram analysis of PFGE proﬁles was performed
using the UPGMA method based on the Dice similarity by
Phoretix 5.0 software (Nonlinear Dynamics, Newcastle-upon-
Thyne, UK).
Multilocus sequence typing (MLST) schemes were applied
for PFGE-unrelated strains of Enterococcus faecalis, E. faecium
and S. aureus (http://www.mlst.net); Escherichia coli (http://mlst.
ucc.ie/mlst/dbs/Ecoli); and K. pneumoniae (http://www.pasteur.
fr/recherche/genopole/PF8/mlst/Kpneumoniae.html). The
E. coli phylogenetic group was also determined by PCR [19].
MLST was represented by the Minimum Spanning Tree algo-
rithm using Phyloviz software (http://www.phyloviz.net)
Antimicrobial susceptibility testing
Antibiotic susceptibility for ampicillin, cefotaxime, imipenem,
gentamicin, kanamycin, erythromycin, tetracycline, ciproﬂoxa-
cin and vancomycin was determined only in the selected iso-
lates for PFGE and MLST typing by agar dilution following the
Clinical and Laboratory Standards Institute guidelines and
breakpoints for each genus and species [20]. All antibiotics
were purchased from Sigma-Aldrich.
Virulence factors carriage
The presence of genes encoding for sex pheromones (ccf, cpd,
cad, cob), cell wall adhesins (efaAfs), the aggregation protein
(agg2), the presence of the protein involved in immune evasion
(epsfs), the extracellular metalloendopeptidase (gelE) and the
cytolisine (cylA) for enterococci were assessed by the proce-
dure described by Eaton and Gasson [21] and modiﬁed by
Reviriego et al. [22].
Carriage of hemolysins (hla, hlb, hlg, hld) and adhesins (fnbA,
clfa, sdrE, ebpS) genes in the S. aureus isolates was determined
by two multiplex PCRs [23], while a single PCR scheme was
used for the detection of the genes encoding the exfoliative
toxin A (eta), toxic shock syndrome toxin (tst), adhesion for
collagen (cna) [24], Panton-Valentin leukocidin components S
and F (pvl-S/F) [25], Panton-Valentin leukocidin components M
and F (pvl-M/F) [26], staphylococcal enterotoxins (se-adej) [27],
polysaccharide intracellular adhesion (icaA) [28], methicillin
resistance (mecA) [29], β-lactamase (blaZ) [30] and iron side-
rophore transporter (sirB) [31]. At least one isolate per infant
and sample obtained during the NICU admission was evaluated
for carriage of virulence factors.ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 936.e1–936.e10
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fants are described in Table 1. In all but one infant, the com-
bination of ampicillin and gentamicin was administered at birth
as empirical treatment, whereas teicoplanin, gentamicin, ami-
kacin and amphotericin B were used in episodes of sepsis
(Fig. 1). Seven infants (27%) had at least one bacteraemic
episode, and the foremost species involved were coagulase-
negative staphylococci (n = 5), Serratia marcescens (n = 3),
K. pneumoniae (n = 2) and P. aeruginosa (n = 2) (Fig. 1).
A total of 296 samples from infant faeces (144 during the
NICU admission and 16 at 2 years old), 86 from mother’s milk,Infant
GA
(weeks)
Weight                          NICU  Discharge
(gr) DM  Gender  (days)  (days)
1 31 2190 V M 5 26
2 30 1150 C M 26 42
3 27 1080 C F 49 60
4 30 2030 C M 8 27
5 30 1760 C M 7 27
6 24 600 C F 99 113
7 27 1540 V M 35 68
8 26 790 V F 68 84
9 25 700 C M 195 196
10 31 1890 V F 5 19
11 32 1310 V F 14 28
12 24 800 V M 41 41
13 30 1350 C F 18 44
14 26 920 V F 97 102
15 29 1040 C F 32 47
16 24 740 V M 97 116
17 25 720 V M 140 144
18 28 1100 C M 43 73
19 31 1430 V F 20 37
20 27 950 C M 54 70
21 24 750 C F 81 92
22 24 870 C M 82 102
23 27 1040 V F 43 68
24 29 680 C M 60 70
25 30 1370 V F 14 41
26 28 1150 C F 31 52
Clo + Amk (4)
Amp + Clo + Am
Gen + Van (3)
Gen (14) +Vanc (9) + 
Amk (13) +Mer (4)
Amb (4) + Fluc (1)
Van + Amk (7)/ Amb
(6)`/ Mica (11) + Fluc (9)
Van + Amk (7)
Gen (4) / Amk (4) Tei (12)
Ceft (7) Amb (8) Flu
SCN
Gen + Clo (1) / Van + Amk (6) /  Ambi (
SCN
P. aeruginosa
FIG. 1. Main characteristic of each preterm infant and his or her NICU ad
resented in different colors. Grey bar indicates NICU stay of infant; different-
of infant; sampling time is indicated in dark inside. Red arrow marks each b
indicate antibiotic treatment of each infant and number of days. Infant 12 is hi
Amp, ampicillin; Clox, cloxacillin; DM, delivery mode; Ery, erythromycin; Flu, ﬂ
Mer, meropenem; Mica, micafungin; NICU, neonatal intensive care unit; Tei,
Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Inf35 from donor milk and 15 from formula milk were processed.
These samples yielded ~4000 bacterial isolates; the most
numerous species was E. faecalis (n = 564), followed by
S. epidermidis (n = 420), S. marcescens (n = 267), E. coli (n = 252),
K. pneumoniae (n = 228), E. faecium (n = 108) and S. aureus
(n = 60) (Table 2). Other less abundant but still relevant species
belonged to Enterobacter (n = 71), Pseudomonas (n = 22) and
Acinetobacter (n = 16) genera, as well as others (Supplementary
Fig. 1).
The number of strains with different PFGE proﬁles coex-
isting in the same infant during NICU admittance ranged be-
tween one and ﬁve for E. faecalis, one and four for E. faecium,
one and ten for S. aureus, and one and three in K. pneumoniae.
The ﬁnal collection of unrelated isolates was composed by 67k + Mer
Gen (36) + Clo (3) + Amk (8) + Mer (37) + Amb (43) + Fluoro (5)
Van + Amk (14) /Mer (3)
Gen + Tei
co (21)
Gen + Van + Amb (5) / Cef (4) / Mero (28)
Gen (6) / Tei (13) / Ery (1) / Ambi (13)
Vanc +Amk + Amb + Fluco
Gen + Clox
K. pneumoniae + P. mirabilis SCN
E. coli
8) Fluco (10)
SCN +  P. aeruginosa
+ K. pneumoniae
S. marcenses
S. marcenses + E. faecalis
S. marcenses
SCN
mittance period, including bacterial pathogens detected in faeces, rep-
colored bars inside grey bar indicate bacterial species detected in faeces
acteraemic episode and corresponding bacterial species; grey arrows
ghlighted in red; this patient died. Amb, amphotericin B; Amk, amikacin;
uconazole; Fluoro, ﬂuorocytosine; GA, gestational age; Gen, gentamicin;
teicoplanin; Vanc, vancomycin.
ectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 936.e1–936.e10
TABLE 2. Bacterial species and total counts in each type of sample
Bacterium Infants (n [ 26)
Faecesa (n [ 144)
Mother’s milk
(n [ 86)
Donor milk
(n [ 35)
Formula milk
(n [ 15)
n CFU/g n CFU/mL n CFU/mL n CFU/mL
Enterococcus faecalis 24 116 103 to 1010 49 101 to 108 15 101 to 106 3 103 to 106
Enterococcus faecium 12 47 105 to 1010 6 104 to 106 1 101 0 —
Staphylococcus epidermidis 26 62 102 to 109 71 101 to 107 8 101 to 105 1 102
Staphylococcus aureus 7 18 105 to 108 8 102 to 106 4 101 to 102 1 102
Escherichia coli 19 62 105 to 1010 10 102 to 105 2 102 1 102
Klebsiella pneumoniae 16 63 105 to 1010 15 102 to 106 5 103 to 107 1 104
Serratia marcescens 25 68 107 to 1010 56 103 to 108 10 102 to 107 4 102 to 106
CFU, colony-forming unit.
aFaecal samples recovered during neonatal intensive care unit admittance; faecal samples of 2-year-olds were not included.
936.e5 Clinical Microbiology and Infection, Volume 21 Number 10, October 2015 CMIE. faecalis, 48 E. coli, 43 K. pneumoniae, 22 E. faecium and 17
S. aureus isolates, which were submitted to antibiotic suscep-
tibility testing and MLST typing. At this stage, S. epidermidis
isolates were not studied further as a result of their highEnterococcus faecalis 
ST64
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ST81
ST40
ST16
ST179
ST537
ST21
ST56
ST30
ST34
1/2/0
6/0/0
15/13/0
7/5/0
5/4/0
1/0/1
5/3/0
0/3/0
0/0/1
0/0/7
0/0/1
0/0/1
gelE cylA ccf efa cpd esp agg2 cad cob Amp
HLR
Gm
HLR
Km Ery Tet Cip Van
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Antibiotic susceptibilityVirulence factors
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ST7
FIG. 2. Summary of genetic diversity, antibiotic resistance proﬁles and virul
versity obtained by MLST and using minimum spanning tree algorithm. Each c
group. Clone number is indicated above circle; number below indicates freq
years). Clones considered to be high risk are marked in bold. STs that are g
related and grey lines when weakly related. (Bottom) Antibiotic susceptibilit
antibiotic resistances are represented in function of frequency (legend). Sam
positive isolates. MLST, multilocus sequence typing; NICU, neonatal intensive
Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectnumber and the high genetic diversity observed; Serratia isolates
were excluded from the analysis because of the lack of an MLST
scheme, while Acinetobacter, Pseudomonas and Enterobacter iso-
lates were scarcely represented in our population.Enterococcus faecium 
gelE cylL ccf efa cpd esp agg2 cad cob Amp
HLR 
Gm
HLR 
Km Ery Tet Cip Van
8
32
65
ST18
ST765
ST675
ST132
9/1/0
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3/2/0
0/0/1
Antibiotic susceptibilityVirulence factors
0% 
<50% 
>50% 
100% 
Fecal samples during
NICU stance
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at 2 years
ence factors obtained for different bacterial species. (Top) Genetic di-
ircle represents MLST clone; size depends on number of isolates in that
uency per origin (faeces during NICU stay, milk samples or faeces at 2
enetically related are connected by black lines when they are strongly
y of each clone. All isolates belonging to same ST were grouped, and
e scheme was followed to describe virulence genes carriage for Gram-
care unit; ST, sequence type.
ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 936.e1–936.e10
CMI Moles et al. Preterm infant gut colonization 936.e6The proportion of high-risk clones detected in faecal samples
during NICU admittance was considerable: ﬁve (ST16-CC8,
ST21-CC21, ST40-CC40, ST56-CC30, ST64-CC8) of the eight
sequence types (STs) found among the E. faecalis isolates; two
(ST18-CC18, ST132-CC18) of three in E. faecium; six (ST8-
CC8, ST30-CC30, ST34-CC30, ST45-CC45, ST121-CC121,
ST1490-CC8) of seven in S. aureus, ﬁve (ST58, ST59, ST69,
ST393, ST2904) of ten in E. coli, and ﬁnally ﬁve (ST25, ST29,
ST35, ST45, ST1547, all of them ﬁt into the CC292) of 12 in
K. pneumoniae. Isolates belonging to these high-risk clones
exhibited resistance to most of the studied antibiotics and
carried multiple virulent factors (Fig. 2).
It is of note that identical STs with the same antibiotic
resistance phenotype and the same virulence factors were also
detected in the milk and formula samples. In infant 14, E. faecalis
ST56 and K. pneumoniae ST505 were simultaneously detected
in faeces and in blood samples during a bacteraemic episode.
Infant 12 died in the NICU after a complicated E. coli
bacteraemia.
Almost all infants were colonized by both E. faecalis ST64
(19/24) and E. faecium ST18 (9/12) clones, while a wider genetic
diversity was observed for the Gram-negative isolates. TheFIG. 2. (continued).
Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infpredominant clones were ST393 for E. coli (8/20) and ST641 for
K. pneumoniae (8/16) (Fig. 3).
Among the E. faecalis and E. faecium isolates, a high level of
antibiotic resistance was observed, especially for tetracycline
(96.7% and 97.4%) and erythromycin (68.8% and 92.9%),
whereas ampicillin resistance was only detected in E. faecium
isolates (92.2%). E. faecalis ST16 and ST40 clones harboured the
highest number of virulence determinants. The most common
virulent genes were gelE (84.3%), ccf (100%) and efaAfs (95.7%)
in E. faecalis isolates, and epsfs (24.8%), gelE (10.3%) and ccf
(10.3%) in E. faecium isolates (Fig. 2).
Globally, hld, fnbA, clfA and icaA were the most frequent
virulence genes in the S. aureus isolates which were susceptible
to the evaluated antibiotics, although 43% of them exhibited
resistance to gentamicin (Fig. 2).
For the E. coli isolates, high percentages of resistance to
tetracycline (46%) and ciproﬂoxacin (32%) were observed
(Fig. 2). For K. pneumoniae, 21% of the isolates were resistant to
tetracycline, while those belonging to the predominant
K. pneumoniae ST641 subgroup displayed resistance to cipro-
ﬂoxacin, imipenem and cefotaxime (Fig. 2).ectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 936.e1–936.e10
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FIG. 2. (continued).
936.e7 Clinical Microbiology and Infection, Volume 21 Number 10, October 2015 CMIIn contrast, isolates from the faecal samples collected from
the 2-year-olds were susceptible to the antibiotics, and the
proportion of high-risk clones was reduced: three (ST16-CC8,
ST40-CC40, ST64-CC8) of seven in E. faecalis; none for
E. faecium and S. aureus; ﬁve (ST10-CC10, ST57, ST59, ST69,
ST131, ST3570-CC23) of ten in E. coli; and ﬁnally one (ST1486-
CC292) of two in K. pneumoniae (Fig. 2).Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and InfectDiscussionRecent studies have demonstrated that bacterial colonization
starts during pregnancy [4,32,33], and in fact the placenta
harbours its own microbiota [34]. According to general
agreement, the ﬁrst gut bacterial colonization constitutes theious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 936.e1–936.e10
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FIG. 3. Persistence and frequency of different STs detected during study period in NICU. Enterococcus faecalis ST64 and ST40 persistent clones are
marked. NICU, neonatal intensive care unit; ST, sequence type.
CMI Moles et al. Preterm infant gut colonization 936.e8core of the future microbiota that can inﬂuence the host’s
gastrointestinal system and general health throughout life. The
deﬁnitive gut microbiota is usually established at the age of 2
years, when the complete diet has been introduced.
In the present work, we analysed the gut microbiota of
preterm infants during their hospital admittance and its main-
tenance over time. In contrast to the next-generation massive
sequence tools, we preferred the classical techniques based on
microbiologic culture in order to collect the bacterial strains
for further characterization. A high proportion of high-risk
clones linked to nosocomial infection was detected both in
the milk administered to the infants and in their faeces. Because
the different milks had been processed and properly stored,
the bacterial load could not be attributed to a dramatic and
continuous food contamination. In the NICU where the pre-
term infants were recruited, single-use sterilized and ready-to-
use preterm formula are purchased, while donor milk is
pasteurized and then submitted to strict microbiologic con-
trols. In contrast, mother’s milk that has not been pasteurized
has been described as containing its own microbiota [35,36],
but its composition and concentration differed considerablyClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Inffrom the results obtained in this study. The milk-sampling
process represents a limitation of our study: we only
collected the milk after the tube or syringe pass, and we cannot
rule out the notion that the milk might have been previously
contaminated.
Orogastric or nasogastric feeding tubes, irrespective of the
feeding regimen, can act as locus for bacterial attachment and
multiplication of numerous opportunistic pathogens [37,38],
and they constitute an important risk factor in the neonatal
infections [39]. In agreement with our results, the feeding
system might act as a reservoir for hospital-adapted high-risk
bacterial clones and contaminate human and formula milk
samples during their passage. After this study, the feeding-
system protocol in the preterm infants of our NICU was sub-
sequently modiﬁed; now the enteral tubes are replaced after a
maximum of 48 hours. Another relevant limitation of our study
was the lack of maternal samples to exclude the existence of
multidrug-resistant clones in the maternal gut or skin micro-
biota. We hypothesized that the clones have a nosocomial
origin, although the maternal source also represents an
important option.ectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 936.e1–936.e10
936.e9 Clinical Microbiology and Infection, Volume 21 Number 10, October 2015 CMIOn the other hand, sepsis is one of the main causes of death
in the NICU, and its prevention and treatment considerably
increase the costs of maintaining sanitation [40]. The main
bacteria causing outbreaks in the NICU is S. epidermidis, fol-
lowed by K. pneumoniae, Serratia spp., E. coli and Enterococcus
spp. Among them, hospital-adapted high-risk clones that exhibit
antibiotic resistance and contain virulence factors are of the
greatest relevance [41,42]. In this study, the structure and main
characteristics of the E. faecalis, E. faecium, S. aureus, E. coli and
K. pneumoniae populations were investigated because they were
considered to be the most representative species in the ana-
lysed samples.
Epidemiologic molecular studies based on MLST schemes
have demonstrated that nosocomial pathogens are usually
grouped in particular lineages: CC10 in E. coli, ST258 in
K. pneumoniae [43], CC2/CC9 in E. faecalis, CC17 in
E. faecium and CC5/CC8/CC30/CC45 in S. aureus [44]. In our
study, the proportion of these high-risk clones detected in
faecal and milk samples was high, although the clonal
replacement observed (Fig. 2) prevented an epidemic situation
in the NICU (Fig. 3).
Despite the elevated amount of enterococci isolates ob-
tained during the NICU stay (564 E. faecalis and 108 E. faecium),
a low genetic diversity was observed (eight E. faecalis and three
E. faecium STs), whereas the remaining genera showed a higher
variability (seven STs of S. aureus from seven infants, ten STs of
E. coli and 12 STs of K. pneumoniae). Only E. faecalis ST64 and
ST40 clones persisted during almost all the studied period
(Fig. 3), which signiﬁed that the epidemiologic measures used
routinely in this NICU are adequate, including hand-washing
protocols, aseptic conditions for milk manipulation, early
detection and further isolation of antibiotic multidrug-resistant
carriers, segregation of patients and staff during epidemic out-
breaks and adequate antibiotic politics in consensus with the
Microbiology Department.
All but one infant received empirical antibiotic therapy after
birth. Although the prophylactic use of antibiotics immediately
after birth usually exerts a negative inﬂuence on early gut
colonization and its protective effect has not been demon-
strated [43], correct antibiotic therapy may be decisive in as-
suring the survival of many preterm infants. However, it is
obvious that this routine practice may be a selector for
antibiotic-resistant isolates that subsequently could be over-
represented, on a long-term basis, in the host’s gut [44].
Therefore, persistence of the high-risk antibiotic-resistant
clones acquired during the NICU stay was evaluated in the
same cohort 2 years after birth. Interestingly, the initial
antibiotic-resistant isolates and high-risk clones were scarcely
detected, but in turn, other clones, mainly observed in theClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectcommunity and initially nondetected, such as E. coli ST131,
ST10-CC10 or ST3570-CC23, were found.
Previous theories generally assume that the ﬁrst bacterial
isolates reaching the almost “microbial-free” gut during or after
birth have a founder effect and therefore that they tend to
persist as members of the gut microbiota throughout life [45].
In contrast, our results showed that after the important se-
lective pressures received early in life by the preterm infants,
the initial nosocomial and antibiotic-resistant high-risk lineages
had been replaced in their gut by antibiotic-susceptible com-
munity lineages at 2 years of age, when perturbations of the
early microbiota decrease and become adultlike microbiota
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